An IND was required to conduct the SB221 study of platinum-resistant ovarian cancer (PROC) with the combination of Sonnet's SON-1010…
The pharmaceutical technology company secures number 867 on the list of America’s fastest-growing privately owned companiesORLANDO, Fla., Aug. 16, 2023…
NEWTOWN, Pa., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company…
CHICAGO, Aug. 16, 2023 (GLOBE NEWSWIRE) -- More than one-third of health system executives participating in a recent survey are…
Transaction led by healthcare specialist investors, TCGX and Aisling Capital$125 million financing upfront with up to an additional $160 million…
ST. LOUIS, Aug. 16, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for…
NCI award (non-dilutive grant) further validates novel personalized off-the-shelf immunotherapy approach; and may facilitate future non-dilutive funding opportunitiesPHILADELPHIA and VANCOUVER,…
The Avertix Guardian™ System, the first and only FDA approved implantable heart attack warning system, now available at the Heart…
IRVINE, Calif., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Petalfast, a route-through-market platform for the cannabis industry, announced its partnership with…
Announces Additional Management Changes; Independent Directors Now Majority of Board TARRYTOWN, NY, Aug. 16, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire…